Compare NTHI & KEQU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NTHI | KEQU |
|---|---|---|
| Founded | 2008 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 106.0M | 96.2M |
| IPO Year | 2023 | 1995 |
| Metric | NTHI | KEQU |
|---|---|---|
| Price | $4.46 | $33.72 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 117.2K | 3.8K |
| Earning Date | 11-05-2026 | 12-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.58 |
| Revenue | $39,990.00 | ★ $138,558,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $58.14 |
| Revenue Growth | N/A | ★ 7.72 |
| 52 Week Low | $2.50 | $32.00 |
| 52 Week High | $12.00 | $43.36 |
| Indicator | NTHI | KEQU |
|---|---|---|
| Relative Strength Index (RSI) | 74.62 | 50.58 |
| Support Level | $4.49 | $33.49 |
| Resistance Level | $4.59 | $38.25 |
| Average True Range (ATR) | 0.38 | 1.11 |
| MACD | 0.16 | 0.17 |
| Stochastic Oscillator | 92.64 | 27.84 |
NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.
Kewaunee Scientific Corp is engaged in the design, manufacture, and installation of laboratory, healthcare, and technical furniture and infrastructure products. Its products include steel and wood casework, fume hoods, adaptable modular systems, movable workstations, stand-alone benches, biological safety cabinets, epoxy resin work surfaces, and sinks. The company operates through two reportable segments: Lab Products Group (LPG), which designs, manufactures, and installs scientific and technical furniture, including steel and wood laboratory cabinetry, fume hoods, flexible systems, work surfaces, workstations, workbenches, and computer enclosures, and the International segment.